MedTrace Logo

Magnetic Resonance Imaging for Detection of Peritoneal Mesothelioma

NCT03867578 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 26

Last updated 2024-07-31

No results posted yet for this study

Summary

For cancers, such as mesothelioma, that spread to the lining of the stomach, detecting the cancer is very difficult with CT or MRI scans. Researchers at the University of Chicago want to find out if the new experimental MRI and ultrasound imaging techniques do a better job of detecting these cancers. Researchers will use new MRI and ultrasound techniques to see if it can find evidence of cancer that has spread to the lining of the abdomen, and right now these new techniques are only used for research.

Conditions

Interventions

DIAGNOSTIC_TEST

HR-MRI

The first 5 patients will undergo HR-MRI scans using different sequence parameters. Results in these patients will then be assessed along with standard CT Imaging to determine which sequences appear to best identify peritoneal disease. The optimal HR-MRI sequences will then be used for the next 19 patients in the Testing phase to formally define their performance compared to standard imaging.

DIAGNOSTIC_TEST

Standard CT Imaging

Standard CT scans will be performed for preoperative imaging in all patients.

DIAGNOSTIC_TEST

Ultrasound

Ultrasound Elastography will be performed using an FDA-Approved diagnostic GE ultrasound scanner

Sponsors & Collaborators

  • University of Chicago

    lead OTHER

Principal Investigators

  • Hedy Kindler, MD · University of Chicago

Study Design

Allocation
NON_RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-10
Primary Completion
2022-07-20
Completion
2022-07-20

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03867578 on ClinicalTrials.gov